Get the latest tech news
Why 'digital twins' could speed up drug discovery
AI can create digital humans and digital organs that can be used in clinical trials.
Perhaps the biggest incentive for drug and device manufacturers to supplement clinical trials with AI digital twins is how it reduces the time it takes, which translates into big cost savings, too. Using biological data from real people, Sanofi creates AI-based simulated patients - not actual clones of specific individuals - that can be interspersed across the control and placebo groups within the trial. "[Due to] aged data collection methods, and low representation of marginalised populations, we could end up in a position where we could still be introducing some of those biases when we're programming virtual recreations of individuals.”
Or read this on BBC News